A phase II trial of fenretinide (LAU-7b) in cystic fibrosis patients in adults.
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2017
At a glance
- Drugs Fenretinide (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Acronyms APPLAUD
- 19 Apr 2017 According to a Laurent Pharmaceuticals media release, company plans to initiate this study later 2017.
- 19 Apr 2017 According to a Laurent Pharmaceuticals media release, the company received the IND approval from the US FDA and the Clinical Trial Application ("CTA") with Health Canada.
- 21 Mar 2016 New trial record